CVN058, a 5-HT3 Receptor Antagonist, Shows Acute, Dose Dependent Improvement of Mismatch Negativity in a Double-Blind, Placebo-Controlled, Single Dose Cross-Over Study in Schizophrenia and Schizoaffective Disorder
Keyword(s):
Keyword(s):
Keyword(s):
Keyword(s):
2001 ◽
Vol 31
(10)
◽
pp. 1607-1614
◽
Keyword(s):
Keyword(s):
2012 ◽
Vol 130
(4)
◽
pp. 886-893.e5
◽
Keyword(s):